The in vitro activity of cefuroxime, a cephalosporin antibiotic, was investigated against 604 isolates and compared with the activity of other fl-lactam compounds. Cefuroxime had activity comparable to that of other cephalosporins, including cefamandole and cefoxitin, against streptococcal and staphylococcal species; most streptococci were inhibited by 0.1 ,ug or less per ml, and staphylococci were inhibited by 1.6 ,ug or less per ml. Enterococci were relatively resistant. Cefuroxime inhibited ,B-lactamase-producing Neisseria gonorrhoeae and Haemophilus influenzae. Cefuroxime had excellent activity against members of the Enterobacteriaceae; 83% of,-lactamase-producing Escherichea coli, 100% of Salmonella, 100% of Klebsiella, 90% of Proteus mirabilis, 95% of Citrobacter, 56% of Enterobacter, and 58% of Shigella were inhibited by 12.5 ,ug/ml. Cefuroxime had activity comparable to that of cefamandole and cefoxitin; it inhibited isolates of E. coli and Klebsiella resistant to cefamandole and inhibited Enterobacter and Citrobacter resistant to cefoxitin. Many isolates of Serratia, some indole-positive strains of Proteus, and Bacteroides fragilis were resistant to cefuroxime. Resistance of cefuroxiime to hydrolysis by ,-lactamases played a major role in its activity against both gram-positive and gram-negative organisms.
There has been a proliferation of new cephalosporin and cephamycin compounds in the past few years. Although compounds such as cephalothin and cephapirin have proven to be useful in the treatment of serious infections produced by gram-positive and gram-negative bacilli, the agents are not active against many ,8-lactamaseproducing members of the Enterobacteriaceae. There has been a steady increase in the level of cephalosporin resistance in some species such as Escherichia coli and Klebsiella pneumoniae; but more important has been the apppearance in hospitalized patients of organisms "intrinsically resistant" to cephalosporins such as cephalothin and cefazolin. Although newer aminoglycosides have been developed, these compounds carry a significant degree of toxicity particularly if used for prolonged periods. Penicillin allergy is a problem in many individuals with serious infection, and clinical studies have indicated that allergic cross-reactions between penicillins and cephalosporins occur rarely (i.e., in less than 10%. ofpatients). For these reasons we have evaluated the in vitro activity of cefuroxime, a new cephalosporin with increased resistance to f8-lactamase hydrolysis. We have compared its activity with that of other cephalosporiiiM and of currently available penicillins in order to determine whether this compound, a molecularly modified agent, would be useful.
MATERIALS AND METHODS
Cefuroxime was a generous gift of Glaxo Pharmaceuticals. All other antimicrobial agents were given by their respective manufacturers. Fresh dilutions of the compounds were prepared daily in sterile medium or distilled water (3, 4) . An inoculum of 10i colony-forming units (CFU) was used unless specified. Minimal inhibitory concentration (MIC) was defined as the lowest concentration of antibiotic that inhibited development of visible growth on agar or in broth. Minimum bactericidal concentration (MBC) was determined by plating 0.1 ml from clear broth tubes to blood agar. The effect of growth medium was determined by using brain heart infusion (BHI), Trypticase soy (TS), nutrient, and Columbia media, all purchased from BBL.
,B-Lactamase assays were performed by using purified enzymes or crude extracts as specified (2, 5) . The microiodometric or spectrophotometric assay was ylococci, whether S. aureus or S. epidermidis, used (2, 6) .
were inhibited by 0.2 jig or less per ml, but the RESULTS MICs for fB-lactamase-containing isolates were RESULTS 0.8 to 6.2 ,ug/ml. Methicillin-resistant S. aureus Table 1 shows the overall in vitro activity of and S. epidermidis were inhibited by 1.6 to 6.2 cefuroxime against 604 bacterial isolates. Cefu-,ug/ml. Strains of cephalothin-resistant S. epiroxime had excellent activity against gram-pos-dermidis were inhibited by 1.6 ,ug or less of itive cocci and bacilli; all of the streptococci cefuroxime per ml. The fastidious gram-negative tested (S. viridans, S. pyogenes, S. agalactiae, cocci and bacilli, Neisseria gonorrhoeae, N. and S. bovis) except for S. faecalis and S. fae-meningiditis, and Haemophilus influenzae, cium (true enterococci) were inhibited by 0.4 ,ug were inhibited by 0.2 to 1.6 ,ug/ml. This included or less per ml, and more than 50% were inhibited /3-lactamase-producing N. gonorrhoeae and H. by 0.1 jig/ml. Non-,8-lactamase-producing staph-influenzae. Table 2 shows the effect of growth medium on the MIC and MBC. There were no major differences in the MICs and MBCs determined in MH, BHI, TS, soy, National Institutes of Health (NIH) (Difco), Columbia, and nutrient broths. All assays were run at the usual pH values of the medium, which ranged from 6.9 to 7.4 . The effect of pH of the medium was also determined by using MH broth adjusted to pH 6, 7, and 8. E. coli, K. pneumoniae, Serratia, and P. morganii were used as test organisms. Regardless of the pH of the medium, the MICs were identical. MBCs were also identical to MICs or only twofold greater. To determine the effect of agar and broth on the MIC, representative susceptible (MIC less than 12.5 ,ug/ml) and resistant Enterobacteriaceae were inoculated onto nutrient agar, MH agar, and BHI agar containing cefuroxime. The MICs either were identical or differed by only twofold in either direction for each medium. It is clear that the osmolality and conductivity of the medium did not alter either the MICs or the MBCs of cefuroxime for either susceptible or resistant organisms, since there were marked differences in osmolality and conductivity of the media used. The osmolality of the TS broth, MH agar, and BHI agar was 440 mOsm, and the conductivity was 12 mS. The osmolality of the NIH medium was 200 mOsm and conductivity 6 mS, whereas the osmolality of nutrient broth was 60 mOsm and conductivity was 1.5 mS.
The effect of inoculum size upon MICs is given in Table 3 12.5 ,ug/ml. Cefuroxime was less active than cefamandole and cefoxitin against indole-positive Proteus. Cefuroxime and cefamandole had similar activity against Serratia, Providencia, and Acinetobacter, and both were less active than cefoxitin against Serratia and Providencia, but more active against Acinetobacter. Table 6 gives a direct comparison of cephalothin, cefuroxime, cefamandole, and cefoxitin against 8-lactamase-producing organisms. It is apparent that the three new agents had similar activity against many organisms. However, there may be an eightfold difference in MICs of the three agents against a particular species.
Resistance to hydrolysis by /3-lactamases. Organisms that were resistant to cephalosporins were selected for study to determine the degree of hydrolysis of cefuroxime by intact bacteria. Table 7 shows the susceptibility (MICs) of the organisms to cephalothin, cephaloridine, cefuroxime, cefamandole, and cefoxitin and the amount of antibiotic hydrolyzed.
Resistance to 83-lactamase hydrolysis by cefuroxime correlated well with the inhibitory activity of the compound. It was clearly not entirely stable to /3-lactamase activity as was cefoxitin, since the f-lactamases of selected species such as some Enterobacter cloacae and Proteus morganii could hydrolyze the compound. In many ways the resistance of cefuroxime to /8-lactamase hydrolysis was similar to the resistance of cefamandole, but cefuroxime was more resistant to hydrolysis. Some strains such as E. coli 3337 or the Citrobacter were resistant even though the isolates did not destroy cefuroxime. In this regard, cefuroxime resembled the activity of cefoxitin against Enterobacter and Citrobacter (4).
Although intact bacterial cells did not hydrolyze cefuroxime, it was possible that strategically placed /8-lactamases could hydrolyze the compound as it entered the bacterial cell. For this reason, partially purified 8-lactamase preparations were used to determine the resistance of cefuroxime to destruction compared with other agents. Cefuroxime was resistant to hydrolysis by the most common E. coli TEM-type enzyme, which had the a 100-fold greater ability to hydrolyze cephaloridine than cephalothin (Table  8) data presented, it appears that its actiyity is demonstrable against both the common grampositive cocci and gram-negative bacilli involved in serious hospital infections, and also those microorganisms that are resistant to the older cephalosporins.
In the present study, cefuroxime's activity was little influenced by the medium used for assay, and it was bactericidal over a wide pH range. Furthermore, the compound's activity was not affected by the osmolality or conductivity of the Evaluation of fl-lactamase hydrolysis of cefuroxime indicates that resistance to destruction is the major factor in its extended spectrum of activity. However, some organisms are resistant without hydrolyzing the compound. It is not possible to predict this. Furthermore, knowledge of the susceptibility of an organism to cefamandole or to cefoxitin will not allow one to predict the susceptibility of the organism to cefuroxime.
